Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
Transl Res
; 232: 75-87, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33453429
Key words
ADAâ¯=â¯adalimumab; ANOVAâ¯=â¯analysis of variance; BsAbâ¯=â¯bispecific antibody; CXCL10â¯=â¯C-X-C motif chemokine 10; FLSâ¯=â¯fibroblast-like synoviocytes; GAPDHâ¯=â¯glyceraldehyde 3-phosphate dehydrogenase; H&Eâ¯=â¯hematoxylin and eosin; IC(50)â¯=â¯the half-maximal inhibitory concentration; ILâ¯=â¯interleukin; Kdâ¯=â¯dissociation constants; LPSâ¯=â¯lipopolysaccharide; Mwâ¯=â¯molecular weight; O.D.â¯=â¯optical density; PBMCsâ¯=â¯peripheral blood mononuclear cells; PBSâ¯=â¯phosphate-buffered saline; RANKLâ¯=â¯receptor activator of nuclear factor kappa-B ligand; RAâ¯=â¯rheumatoid arthritis; SEMâ¯=â¯standard error of the mean; SPRâ¯=â¯surface plasmon resonance; ScFvâ¯=â¯single-chain variable fragment; TNF-αâ¯=â¯tumor necrosis factor-α; TRAPâ¯=â¯tartrate-resistant acid phosphatase; Tg mouseâ¯=â¯transgenic mouse; VHâ¯=â¯variable heavy chain; VLâ¯=â¯variable light chain; bDMARDsâ¯=â¯biological disease-modifying anti-rheumatic drugs; cDNAâ¯=â¯complementary DNA; qPCRâ¯=â¯quantitative real-time polymerase chain reaction
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Experimental
/
Arthritis, Rheumatoid
/
Tumor Necrosis Factor-alpha
/
Antibodies, Bispecific
/
Chemokine CXCL10
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Transl Res
Journal subject:
MEDICINA
/
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Year:
2021
Document type:
Article